Xtrackers MSCI美國氣候行動股票ETF USCA 深 滬
已收盤 06-18 16:00:00 美东时间
43.88
+0.423
+0.97%
華盛通- 最 高43.96
- 今 開43.77
- 成交量 8076股
- 最 低 43.77
- 昨 收 43.4573
- 總市值 31.82亿
- 52周最高 44.906
- 市盈率 靜 --
- 換手率 0.01%
- 52周最低 37.756
- 委 比 81.82%
- 總股本 7252.50万
- 歷史最高 44.906
- 量 比 2.21
- 振 幅 0.44%
- 歷史最低 23.0859
- 每 手 1
- 風險率 1.64%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Aptose Highlights Promising TUSCANY Triplet Data in AML
Aptose Biosciences ( ($TSE:APS) ) has issued an update. On June 15, 2026, Aptos...
06-15 20:43
HighPeak Energy Files $150m At-The-Market Common Stock Offering
HighPeak Energy, Inc.Up to $150,000,000Common StockWe have entered into a sales agreement, dated May 6, 2026 (the "Sales Agreement"), with Roth Capital Partners, LLC as lead agent (Roth or the "Lead Agent") and USCA
05-07 05:56
LIVE MARKETS-Data mishmash: Jobless claims, industrial output, Philly Fed
LIVE MARKETS-Data mishmash: Jobless claims, industrial output, Philly Fed Main US indexes slip Cons Disc weakest S&P 500 sector; Energy leads gainers Euro STOXX 600 index off ~0.1% Dollar gains; US crude up >2%; gold slips; bitcoin off >1% US 10-Year Treasury yield edges up to ~4.29% Welcome to the
04-16 22:45
Caris Life Sciences to present five studies at the USCAP Annual Meeting
Caris Life Sciences to present five studies at the USCAP Annual Meeting Caris will attend the United States and Canadian Academy of Pathology (USCAP) Annual Meeting in San Antonio, Texas on March 21-26, 2026. The company said it will present one oral session on March 24, 2026, and four posters on Ma
03-11 20:30
LIVE MARKETS-Hump day data dump: Durable goods, industrial output, housing starts, mortgage demand
LIVE MARKETS-Hump day data dump: Durable goods, industrial output, housing starts, mortgage demand US stocks rally; Nasdaq out front Tech leads S&P sector gainers; real estate down most Euro STOXX 600 index up ~1.2% Dollar up; gold gains >2%; crude up >3%; bitcoin slips US 10-Year Treasury yield ris
02-19 00:47
Aptose Biosciences Reports 100% Response Rate in AML Trial With Tuspetinib Combination Therapy
Aptose Biosciences Inc. announced updated clinical data for its lead compound tuspetinib (TUS) in combination with venetoclax (VEN) and azacitidine (AZA), presented at the 67th American Society of Hem...
2025-12-06 21:00
BRIEF-Google Threat Intelligence Is Tracking A Long-Running And Adaptive Cyber Espionage Campaign By Apt24
Nov 20 (Reuters) - Alphabet Inc GOOGL.O: GOOGLE CLOUD : GOOGLE THREAT INTELLIGENCE GROUP (GTIG) IS TRACKING A LONG-RUNNING AND ADAPTIVE CYBER ESPIONAGE CAMPAIGN BY APT24 GOOGLE CLOUD : APT24 HAS BEEN ...
2025-11-21 00:05
美股盘后 | Paramount Skydance Corp. Ordinary Shares - Class B涨6.16%，Rocket Lab涨6.15%
Paramount Skydance Corp. Ordinary Shares - Class B涨6.16%；Rocket Lab涨6.15%；Blue Owl Capital Inc. Class A Common Stock涨2.62%
2025-11-11 07:11
Aptose Biosciences Unveils Positive TUSCANY Trial Data for Tuspetinib in Newly Diagnosed AML
Aptose Biosciences Inc. has announced that an abstract from its ongoing TUSCANY clinical trial evaluating tuspetinib in combination with standard of care venetoclax and azacitidine for patients with n...
2025-11-03 22:00
